Acute pancreatitis in the use of canagliflozin: A rare side-effect of the novel therapy for type 2 diabetes mellitus.
about
Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature.An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus.SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
P2860
Acute pancreatitis in the use of canagliflozin: A rare side-effect of the novel therapy for type 2 diabetes mellitus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Acute pancreatitis in the use ...... for type 2 diabetes mellitus.
@en
Acute pancreatitis in the use ...... for type 2 diabetes mellitus.
@nl
type
label
Acute pancreatitis in the use ...... for type 2 diabetes mellitus.
@en
Acute pancreatitis in the use ...... for type 2 diabetes mellitus.
@nl
prefLabel
Acute pancreatitis in the use ...... for type 2 diabetes mellitus.
@en
Acute pancreatitis in the use ...... for type 2 diabetes mellitus.
@nl
P2093
P2860
P356
P1476
Acute pancreatitis in the use ...... for type 2 diabetes mellitus.
@en
P2093
Charat Thongprayoon
Narat Srivali
Patompong Ungprasert
Wisit Cheungpasitporn
P2860
P304
P356
10.4103/0976-0105.160753
P577
2015-06-01T00:00:00Z